Long-term survival after allogeneic stem cell transplantation for advanced stage multiple myeloma

被引：11
作者：
Vekemans, Marie-Christiane [1 ]
Michaux, Lucienne [1 ]
Van den Neste, Eric [1 ]
Ferrant, Augustin [1 ]
机构：
[1] Clin Univ St Luc, Dept Haematol, UCL, B-1200 Brussels, Belgium
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2014年 / 166卷 / 04期
关键词：
multiple myeloma; transplantation; graft-versus-host disease; toxicity; outcome; RISK;
D O I：
10.1111/bjh.12881
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：616 / 618
页数：4
相关论文
共 9 条
  • [1] A comparison of allografting with autografting for newly diagnosed myeloma
    Bruno, Benedetto
    Rotta, Marcello
    Patriarca, Francesca
    Mordini, Nicola
    Allione, Bernardino
    Carnevale-Schianca, Fabrizio
    Giaccone, Luisa
    Sorasio, Roberto
    Omede, Paola
    Baldi, Ileana
    Bringhen, Sara
    Massaia, Massimo
    Aglietta, Massimo
    Levis, Alessandro
    Gallamini, Andrea
    Fanin, Renato
    Palumbo, Antonio
    Storb, Rainer
    Ciccone, Giovannino
    Boccadoro, Mario
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (11) : 1110 - 1120
  • [2] Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients
    Caballero-Velazquez, Teresa
    Lopez-Corral, Lucia
    Encinas, Cristina
    Castilla-Llorente, Cristina
    Martino, Rodrigo
    Rosinol, Laura
    Sampol, Antonia
    Caballero, Dolores
    Serrano, David
    Heras, Inmaculada
    San Miguel, Jesus
    Perez-Simon, Jose A.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (04) : 474 - 482
  • [3] Reduced-intensity conditioning for myeloma:: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning
    Crawley, Charles
    Iacobelli, Simona
    Bjorkstrand, Bo
    Apperley, Jane F.
    Niederwieser, Dietger
    Gahrton, Gosta
    [J]. BLOOD, 2007, 109 (08) : 3588 - 3594
  • [4] Novel Strategies for Immunotherapy in Multiple Myeloma: Previous Experience and Future Directions
    Danylesko, Ivetta
    Beider, Katia
    Shimoni, Avichai
    Nagler, Arnon
    [J]. CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2012,
  • [5] Donor cell leukemia developing after hematopoietic stem cell transplantation for multiple myeloma
    Havelange, V.
    Antoine-Poirel, H.
    Saussoy, P.
    Van Den Neste, E.
    Ferrant, A.
    [J]. ACTA CLINICA BELGICA, 2006, 61 (02): : 82 - 86
  • [6] Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial
    Kneppers, Evelien
    van der Holt, Bronno
    Kersten, Marie-Jose
    Zweegman, Sonja
    Meijer, Ellen
    Huls, Gerwin
    Cornelissen, Jan J.
    Janssen, Jeroen J.
    Huisman, Cynthia
    Cornelisse, Petra B.
    Bruijnen, Cheryl P.
    Emmelot, Maarten
    Sonneveld, Pieter
    Lokhorst, Henk M.
    Mutis, Tuna
    Minnema, Monique C.
    [J]. BLOOD, 2011, 118 (09) : 2413 - 2419
  • [7] Proteasome Inhibition and Allogeneic Hematopoietic Stem Cell Transplantation: A Review
    Koreth, John
    Alyea, Edwin P.
    Murphy, William J.
    Welniak, Lisbeth A.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (12) : 1502 - 1512
  • [8] Late relapses following reduced intensity allogeneic transplantation in patients with multiple myeloma: a long-term follow-up study
    Sahebi, Firoozeh
    Shen, Yan
    Thomas, Sandra H.
    Rincon, Amalia
    Murata-Collins, Joyce
    Palmer, Joycelynne
    Krishnan, Amrita Y.
    Karanes, Chatchada
    Htut, Myo
    Somlo, George
    Forman, Stephen J.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2013, 160 (02) : 199 - 206
  • [9] Postallograft lenalidomide induces strong NK cell-mediated antimyeloma activity and risk for T cell-mediated GvHD: Results from a phase I/II dose-finding study
    Wolschke, Christine
    Stuebig, Thomas
    Hegenbart, Ute
    Schoenland, Stefan
    Heinzelmann, Marion
    Hildebrandt, York
    Ayuk, Francis
    Atanackovic, Djordje
    Dreger, Peter
    Zander, Axel
    Kroeger, Nicolaus
    [J]. EXPERIMENTAL HEMATOLOGY, 2013, 41 (02) : 134 - 142
1